{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:49:29Z","timestamp":1775688569210,"version":"3.50.1"},"reference-count":232,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.autrev.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T23:20:14Z","timestamp":1473981614000},"page":"1181-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases"],"prefix":"10.1016","volume":"15","author":[{"given":"Tanima","family":"Bose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Diedrichs-M\u00f6hring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhild","family":"Wildner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.09.001_bb0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.rdc.2008.08.004","article-title":"New concepts in the pathogenesis of Sjogren's syndrome","volume":"34","author":"Delaleu","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2016.09.001_bb0010","series-title":"The Epidemiology of Dry Eye Disease","author":"Stapleton","year":"2015"},{"key":"10.1016\/j.autrev.2016.09.001_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-0124(12)70289-6","article-title":"Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease","volume":"7","author":"Nguyen","year":"2009","journal-title":"Ocul Surf"},{"key":"10.1016\/j.autrev.2016.09.001_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1601-0825.2002.02846.x","article-title":"Current issues in Sjogren's syndrome","volume":"8","author":"Jonsson","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2016.09.001_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/clim.2002.5189","article-title":"Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy","volume":"103","author":"van Blokland","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12016-007-8012-7","article-title":"Animal models of Sjogren's syndrome","volume":"32","author":"Jonsson","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/ar599","article-title":"Genetic aspects of Sjogren's syndrome","volume":"4","author":"Bolstad","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.exer.2004.07.002","article-title":"Tear film and ocular surface tests in animal models of dry eye: uses and limitations","volume":"79","author":"Barabino","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0045","first-page":"231","article-title":"Experimental autoimmune uveoretinitis. Ultrastructure of chorioretinal lesions induced in guinea pigs by immunization against the outer rods of the bovine retina","volume":"36","author":"De Kozak","year":"1976","journal-title":"Arch Ophtalmol (Paris)"},{"key":"10.1016\/j.autrev.2016.09.001_bb0050","first-page":"51","article-title":"Humoral and cellular immunity to retinal antigens in guinea pigs","volume":"16","author":"de Kozak","year":"1976","journal-title":"Mod Probl Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3109\/02713688708997561","article-title":"Response of guinea pigs to the synthetic peptide-M of the uveitogenic, retinal S-antigen: antisera immunofluorescent reactivity on normal guinea pig retina","volume":"6","author":"Kalsow","year":"1987","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-4835(87)80086-6","article-title":"Correlation between histopathological, clinical and biochemical parameters in S-antigen-induced experimental autoimmune uveitis in guinea-pigs","volume":"45","author":"Mahlberg","year":"1987","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0008-8749(88)90193-1","article-title":"Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen","volume":"115","author":"Singh","year":"1988","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/02713688709025196","article-title":"IRBP from bovine retina is poorly uveitogenic in guinea pigs and is identical to A-antigen","volume":"6","author":"Vistica","year":"1987","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0075","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4049\/jimmunol.136.8.2875","article-title":"S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis","volume":"136","author":"Gregerson","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4049\/jimmunol.143.1.79","article-title":"Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis","volume":"143","author":"Donoso","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/02713688809033202","article-title":"Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats","volume":"7","author":"Sanui","year":"1988","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0090","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1084\/jem.169.6.1947","article-title":"Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP)","volume":"169","author":"Sanui","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/02713689409025141","article-title":"Interphotoreceptor retinoid-binding protein derived peptide can induce experimental autoimmune uveoretinitis in various rat strains","volume":"13","author":"Sasamoto","year":"1994","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/02713689008999438","article-title":"The mouse as a model of experimental autoimmune uveoretinitis (EAU)","volume":"9","author":"Caspi","year":"1990","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0105","first-page":"946","article-title":"Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype","volume":"36","author":"Silver","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0110","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1167\/iovs.07-0868","article-title":"Repertoire analysis and new pathogenic epitopes of IRBP in C57BL\/6 (H-2b) and B10.RIII (H-2r) mice","volume":"49","author":"Cortes","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0115","first-page":"127","article-title":"Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype","volume":"41","author":"Avichezer","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0165-5728(01)00341-1","article-title":"Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope","volume":"118","author":"Hankey","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0125","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1167\/iovs.15-17280","article-title":"Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype","volume":"56","author":"Mattapallil","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/jaut.1993.1048","article-title":"Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat","volume":"6","author":"de Smet","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713689008999435","article-title":"A new perspective of S-antigen from immunochemical analysis","volume":"9","author":"Gregerson","year":"1990","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.146.1.75","article-title":"Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes","volume":"146","author":"Merryman","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0145","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3109\/02713688709034888","article-title":"S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats","volume":"6","author":"Donoso","year":"1987","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0014-4835(90)90125-E","article-title":"S-antigen: from gene to autoimmune uveitis","volume":"50","author":"Shinohara","year":"1990","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/intimm\/dxg090","article-title":"Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo","volume":"15","author":"Wildner","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000119863","article-title":"Animal models of Vogt-Koyanagi-Harada disease (sympathetic ophthalmia)","volume":"40","author":"Yamaki","year":"2008","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0165","first-page":"106","article-title":"An 18-mer peptide derived from the retinal S antigen induces uveitis and pinealitis in primates","volume":"77","author":"Hirose","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bjo.77.1.46","article-title":"Pinealitis accompanying equine recurrent uveitis","volume":"77","author":"Kalsow","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exer.2002.2011","article-title":"Immunopathology of recurrent uveitis in spontaneously diseased horses","volume":"75","author":"Deeg","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-1229(87)90133-4","article-title":"Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen","volume":"43","author":"Fox","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OPX.0b013e31816225ed","article-title":"Dry eye and blink rate simulation with a pig eye model","volume":"85","author":"Choy","year":"2008","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00003226-200405000-00015","article-title":"Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations","volume":"23","author":"Nakamura","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2016.09.001_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-1229(87)90176-0","article-title":"Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice","volume":"42","author":"Jonsson","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12016-011-8288-5","article-title":"Animal models in autoimmune diseases: lessons learned from mouse models for Sjogren's syndrome","volume":"42","author":"Lee","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3313","article-title":"Sjogren's syndrome: studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.09.001_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaut.2009.09.009","article-title":"Sjogren syndrome: advances in the pathogenesis from animal models","volume":"33","author":"Chiorini","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb0215","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0220","first-page":"251","article-title":"Alum, an aluminum-based adjuvant, induces Sjogren's syndrome-like disorder in mice","volume":"32","author":"Bagavant","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0225","first-page":"2898","article-title":"The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment","volume":"40","author":"Silver","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9394(82)90069-1","article-title":"Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen","volume":"94","author":"Nussenblatt","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/bjo.61.1.62","article-title":"HLA antigens and uveitis","volume":"61","author":"Ohno","year":"1977","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0240","first-page":"4","article-title":"Acute anterior uveitis and HLA-B27 in families","volume":"12","author":"Saari","year":"1977","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0245","first-page":"1257","article-title":"Letter: HLA B27 tissular antigen in patients with acute anterior uveitis. Preliminary results","volume":"5","author":"Saraux","year":"1976","journal-title":"Nouv Presse Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-0039.1976.tb00553.x","article-title":"HLA and juvenile chronic polyarthritis","volume":"8","author":"Veys","year":"1976","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2016.09.001_bb0255","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.4238\/2014.July.2.8","article-title":"HLA-B51 subtypes in Turkish patients with Behcet's disease and their correlation with clinical manifestations","volume":"13","author":"Demirseren","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/bs.pmbts.2015.04.009","article-title":"Molecular Genetic Advances in Uveitis","volume":"134","author":"Hou","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0265","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Behcet's disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0270","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1073\/pnas.1407307111","article-title":"HLA-B*51 the primary risk in Behcet disease","volume":"111","author":"Wallace","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.09.001_bb0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09273940902999356","article-title":"Immune response genes in uveitis","volume":"17","author":"Du","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2016.09.001_bb0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-014-0017-9","article-title":"Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center","volume":"4","author":"Prete","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.autrev.2016.09.001_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2013.12.006","article-title":"HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis","volume":"157","author":"Reddy","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0290","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1073\/pnas.051595998","article-title":"Spontaneous retinopathy in HLA-A29 transgenic mice","volume":"98","author":"Szpak","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.09.001_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.001_bb0300","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0198-8859(97)00033-5","article-title":"Experimental autoimmune uveitis in HLA-B27 transgenic mice","volume":"53","author":"Willbanks","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0305","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1172\/JCI15155","article-title":"A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice","volume":"111","author":"Pennesi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.09.001_bb0310","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.4049\/jimmunol.1101247","article-title":"Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells","volume":"187","author":"Mattapallil","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0315","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2249.1997.4571356.x","article-title":"Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals","volume":"109","author":"Thurau","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/02713688108998359","article-title":"S antigen-induced experimental autoimmune uveo-retinitis in rats","volume":"1","author":"de Kozak","year":"1981","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0325","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02713689208999519","article-title":"Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin","volume":"11","author":"Dua","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-4835(88)90030-9","article-title":"Rhodopsin-induced experimental autoimmune uveoretinitis: dose-dependent clinicopathological features","volume":"47","author":"Schalken","year":"1988","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0335","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1076\/ceyr.22.4.304.5503","article-title":"Uveitopathogenic sites in recoverin","volume":"22","author":"Ohkoshi","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0340","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1097-4547(19960615)44:6<513::AID-JNR1>3.0.CO;2-E","article-title":"Myelin basic protein specific T-helper cells induce experimental anterior uveitis","volume":"44","author":"Adamus","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0345","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.180.3.817","article-title":"Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia","volume":"180","author":"Kojima","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0350","first-page":"1056","article-title":"Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body","volume":"36","author":"Bora","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0355","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1074\/mcp.M500352-MCP200","article-title":"Identification and functional validation of novel autoantigens in equine uveitis","volume":"5","author":"Deeg","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2016.09.001_bb0360","first-page":"2258","article-title":"RPE65 is highly uveitogenic in rats","volume":"43","author":"Ham","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0365","first-page":"298","article-title":"Lymphocyte responses to peptide M and to retinal S-antigen in uveitis patients","volume":"34","author":"Hirose","year":"1990","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0370","first-page":"3233","article-title":"Human S-antigen determinant recognition in uveitis","volume":"42","author":"de Smet","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0375","doi-asserted-by":"crossref","first-page":"39245","DOI":"10.1155\/2007\/39245","article-title":"CRALBP is a highly prevalent autoantigen for human autoimmune uveitis","volume":"2007","author":"Deeg","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0380","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molimm.2014.07.009","article-title":"Spontaneously relapsing\u2013remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease","volume":"63","author":"Huber","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2005.02.023","article-title":"The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance","volume":"164","author":"Diedrichs-Mohring","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0390","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1167\/iovs.14-15518","article-title":"A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing\u2013remitting and chronic experimental autoimmune uveitis","volume":"56","author":"Diedrichs-Mohring","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.05.021","article-title":"Uveitis in a patient treated with Bacille-Calmette-Guerin: possible antigenic mimicry of mycobacterial and retinal antigens","volume":"116","author":"Garip","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2016.09.001_bb0400","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxm148","article-title":"Antigen-dependent monophasic or recurrent autoimmune uveitis in rats","volume":"20","author":"Diedrichs-Mohring","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0405","first-page":"393","article-title":"Immune responses to retinal autoantigens and peptides in equine recurrent uveitis","volume":"42","author":"Deeg","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0410","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/1521-4141(200209)32:9<2598::AID-IMMU2598>3.0.CO;2-#","article-title":"Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease","volume":"32","author":"Deeg","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0415","first-page":"3","article-title":"Equine Recurrent Uveitis: Immunization of ponies with retinal S Antigen","volume":"2","author":"Hines","year":"1990","journal-title":"Prog Vet Comp Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0420","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1167\/iovs.03-1226","article-title":"The uveitogenic potential of retinal S-antigen in horses","volume":"45","author":"Deeg","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0425","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1167\/iovs.05-0789","article-title":"Inter- and intramolecular epitope spreading in equine recurrent uveitis","volume":"47","author":"Deeg","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0430","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/art.11352","article-title":"Development of autoimmune exocrinopathy resembling Sjogren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells","volume":"48","author":"Arakaki","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.001_bb0435","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078508","article-title":"Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease","volume":"8","author":"Coursey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0445","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1167\/iovs.14-14481","article-title":"CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease","volume":"55","author":"Kodati","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2007.02614.x","article-title":"B-lymphocyte depletion ameliorates Sjogren's syndrome in Id3 knockout mice","volume":"122","author":"Hayakawa","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2016.09.001_bb0455","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10875-012-9663-6","article-title":"B-cell tolerance defects in the B6.Aec1\/2 mouse model of Sjogren's syndrome","volume":"32","author":"Meng","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0460","first-page":"407031","article-title":"Dysfunction of lacrimal and salivary glands in Sjogren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model","volume":"2011","author":"Hayashi","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0465","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.09.001_bb0470","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1167\/iovs.11-9299","article-title":"Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease","volume":"53","author":"Stern","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0475","first-page":"247","article-title":"Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjogren's syndrome","volume":"25","author":"Lee","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0480","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren's syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08916939809008035","article-title":"Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice","volume":"27","author":"Robinson","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2016.09.001_bb0490","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1167\/iovs.12-9547","article-title":"Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease","volume":"53","author":"Lee","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0495","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1600-0714.2012.01136.x","article-title":"Involvement of toll-like receptors in autoimmune sialoadenitis of the non-obese diabetic mouse","volume":"41","author":"Shimizu","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0500","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1167\/iovs.12-10739","article-title":"Toll-like receptor expression and activation in mice with experimental dry eye","volume":"54","author":"Redfern","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028727","article-title":"Activation of the alternative NFkappaB pathway improves disease symptoms in a model of Sjogren's syndrome","volume":"6","author":"Gilboa-Geffen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0510","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.175.10.6303","article-title":"Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity","volume":"175","author":"Su","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0515","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1167\/iovs.07-0233","article-title":"Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency","volume":"48","author":"Su","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0520","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.09.001_bb0525","first-page":"1547","article-title":"Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis","volume":"42","author":"Crane","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0530","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.168.5.2483","article-title":"Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation","volume":"168","author":"Foxman","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0535","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-002-0556-x","article-title":"Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice","volume":"241","author":"Keino","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0540","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1167\/iovs.09-3434","article-title":"Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2","volume":"50","author":"Dagkalis","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0545","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2567.2009.03046.x","article-title":"CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis","volume":"128","author":"Dagkalis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2016.09.001_bb0550","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1167\/iovs.14-15495","article-title":"Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2(\u2212)\/(\u2212)CX(3)CR1gfp\/gfp mice","volume":"55","author":"Zhao","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0555","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/jlb.0305130","article-title":"Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis","volume":"79","author":"Crane","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0560","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/immu.200310014","article-title":"Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis","volume":"33","author":"Crane","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0565","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/002215540004800802","article-title":"Age-related alterations in IL-1beta, TNF-alpha, and IL-6 concentrations in parotid acinar cells from BALB\/c and non-obese diabetic mice","volume":"48","author":"Yamakawa","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.autrev.2016.09.001_bb0570","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2249.1994.tb07030.x","article-title":"Induction of autoimmune disease by graft-versus-host reaction across MHC class II difference: modification of the lesions in IL-6 transgenic mice","volume":"95","author":"Kimura","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0575","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2012.01.034","article-title":"Efficacy of topical blockade of interleukin-1 in experimental dry eye disease","volume":"154","author":"Okanobo","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0580","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar2888","article-title":"Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjogren's syndrome","volume":"11","author":"Vosters","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.09.001_bb0585","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.24980","article-title":"Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome","volume":"60","author":"Vosters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.001_bb0590","doi-asserted-by":"crossref","first-page":"L837","DOI":"10.1152\/ajplung.00134.2006","article-title":"IL-12 overexpression in mice as a model for Sjogren lung disease","volume":"291","author":"McGrath-Morrow","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0595","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/cimm.1996.0072","article-title":"In vivo role of IL-10 and IL-12 during development of Sjogren's syndrome in MRL\/lpr mice","volume":"168","author":"Yanagi","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0600","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0605","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.10.004","article-title":"A chimeric human\u2013mouse model of Sj\u00f6gren's syndrome","volume":"156","author":"Young","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0615","first-page":"935","article-title":"Increased serum levels of interleukin 10 in Sjogren's syndrome; correlation with increased IgG1","volume":"27","author":"Perrier","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098390","article-title":"Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sj\u00f6gren's Syndrome","volume":"9","author":"Arakaki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0625","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0630","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0022034513483315","article-title":"Type I interferon receptor deficiency prevents murine Sjogren's syndrome","volume":"92","author":"Szczerba","year":"2013","journal-title":"J Dent Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0635","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1189\/jlb.1110611","article-title":"Interferon-gamma-secreting NK cells promote induction of dry eye disease","volume":"89","author":"Chen","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077605","article-title":"Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjogren's syndrome in a mouse model","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0645","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molimm.2011.08.012","article-title":"Contribution of IL-13 to early exocrinopathy in Id3\u2212\/\u2212 mice","volume":"49","author":"Mahlios","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0650","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/mi.2013.61","article-title":"CD8(+) cells regulate the T helper-17 response in an experimental murine model of Sjogren syndrome","volume":"7","author":"Zhang","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0655","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaut.2006.11.003","article-title":"Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice","volume":"27","author":"Sharma","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb0660","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/art.22715","article-title":"Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands","volume":"56","author":"Nandula","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.001_bb0665","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","article-title":"IL-14 alpha, the nexus for primary Sjogren's disease in mice and humans","volume":"130","author":"Shen","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0670","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1472-6831-13-51","article-title":"Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren's syndrome","volume":"13","author":"Xuan","year":"2013","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.autrev.2016.09.001_bb0675","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.1203440","article-title":"Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN","volume":"191","author":"Shen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0680","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1600-0714.2012.01175.x","article-title":"Local suppression of IL-21 in submandibular glands retards the development of Sjogren's syndrome in non-obese diabetic mice","volume":"41","author":"Liu","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0685","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/cimm.1997.1121","article-title":"Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis","volume":"178","author":"Xu","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0690","first-page":"754","article-title":"T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis","volume":"39","author":"Prendergast","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0695","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0700","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0705","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","article-title":"Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis","volume":"20","author":"Yoshimura","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0710","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0715","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0720","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.4049\/jimmunol.158.12.5997","article-title":"IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response","volume":"158","author":"Jones","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0725","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/exer.2000.0860","article-title":"Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice","volume":"71","author":"Avichezer","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0730","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1385\/IR:23:1:59","article-title":"Cytokines in posterior uveitis: an update","volume":"23","author":"Singh","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0735","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bjo.82.10.1195","article-title":"Treatment of uveitis with recombinant human interleukin-13","volume":"82","author":"Roberge","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049008","article-title":"Dynamics of intraocular IFN-gamma, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis","volume":"7","author":"Kaufmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0745","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2013.04.001","article-title":"What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells","volume":"12","author":"Wildner","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.001_bb0750","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0755","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","article-title":"Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses","volume":"91","author":"Hohki","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0760","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2015.08.012","article-title":"CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6","volume":"140","author":"Iwahashi","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0765","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/ken489","article-title":"Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis","volume":"48","author":"Yoshimura","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.09.001_bb0770","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-2249.2002.01969.x","article-title":"Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene","volume":"130","author":"De Kozak","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0775","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/hum.2005.16.1037","article-title":"Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis","volume":"16","author":"Smith","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.autrev.2016.09.001_bb0780","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/exer.1999.0808","article-title":"Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance?","volume":"70","author":"Sun","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0785","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.4049\/jimmunol.180.8.5423","article-title":"Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms","volume":"180","author":"Agarwal","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0790","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.4049\/jimmunol.158.8.3557","article-title":"Immune deviation in relation to ocular immune privilege","volume":"158","author":"Streilein","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0795","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1167\/iovs.04-0362","article-title":"Thrombospondin plays a vital role in the immune privilege of the eye","volume":"46","author":"Zamiri","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0800","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1189\/jlb.72.5.946","article-title":"Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2","volume":"72","author":"Namba","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0805","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0898-6568(01)00171-1","article-title":"Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion. Involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs, pathway","volume":"13","author":"Chen","year":"2001","journal-title":"Cell Signal"},{"key":"10.1016\/j.autrev.2016.09.001_bb0810","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI116778","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells","volume":"92","author":"Marui","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.09.001_bb0815","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0820","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/09273949709085056","article-title":"Tumor necrosis factor and nitric oxide production by resident retinal glial cells from rats presenting hereditary retinal degeneration","volume":"5","author":"de Kozak","year":"1997","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2016.09.001_bb0825","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.02-0199","article-title":"Pathogenic role of retinal microglia in experimental uveoretinitis","volume":"44","author":"Rao","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.12-10138","article-title":"Effects of systemic and intravitreal TNF-alpha inhibition in experimental autoimmune uveoretinitis","volume":"54","author":"Busch","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0835","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2249.2012.04567.x","article-title":"Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitis","volume":"168","author":"Khera","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0840","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.4049\/jimmunol.175.10.6286","article-title":"A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis","volume":"175","author":"Calder","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0845","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0901340","article-title":"TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis","volume":"183","author":"Raveney","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0850","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0855","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1167\/iovs.09-5003","article-title":"Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization","volume":"51","author":"Jasielska","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0860","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archophthalmol.2009.316","article-title":"Essential role for c-Jun N-terminal kinase 2 in corneal epithelial response to desiccating stress","volume":"127","author":"De Paiva","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0865","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix Metalloproteinase-9 Knockout Confers Resistance to Corneal Epithelial Barrier Disruption in Experimental Dry Eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0870","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-1596-9-5","article-title":"Dry eye management in a Sjogren's syndrome mouse model by inhibition of p38-MAPK pathway","volume":"9","author":"Ma","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0875","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1167\/iovs.10-6350","article-title":"sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB\/c mouse model","volume":"52","author":"Wei","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0880","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1601-0825.2011.01819.x","article-title":"Loss of PKCdelta results in characteristics of Sjogren's syndrome including salivary gland dysfunction","volume":"17","author":"Banninger","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2016.09.001_bb0885","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jop.12209","article-title":"Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjogren's syndrome in NOD\/Ltj mouse","volume":"43","author":"Shi","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb0890","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4049\/jimmunol.179.1.382","article-title":"IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjogren's syndrome-like disease of the nonobese diabetic mouse","volume":"179","author":"Nguyen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0895","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2010.07.017","article-title":"Effector T cells driving monophasic vs. relapsing\/remitting experimental autoimmune uveitis show unique pathway signatures","volume":"48","author":"von Toerne","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0900","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1016\/j.jprot.2012.04.052","article-title":"Label-free LC-MSMS analysis of vitreous from autoimmune uveitis reveals a significant decrease in secreted Wnt signalling inhibitors DKK3 and SFRP2","volume":"75","author":"Hauck","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.autrev.2016.09.001_bb0905","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/pmic.200600795","article-title":"Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier","volume":"7","author":"Deeg","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.autrev.2016.09.001_bb0910","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1021\/pr400837f","article-title":"Expression changes and novel interaction partners of talin 1 in effector cells of autoimmune uveitis","volume":"12","author":"Degroote","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0915","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1167\/iovs.10-6475","article-title":"Changes in matrix metalloproteinase network in a spontaneous autoimmune uveitis model","volume":"52","author":"Hofmaier","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb0920","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2005.07.021","article-title":"Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins","volume":"168","author":"Takase","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0925","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0930","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cxo.12128","article-title":"Corneal epithelial cell viability of an ex vivo porcine eye model","volume":"97","author":"Chan","year":"2014","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.autrev.2016.09.001_bb0935","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.ico.0000127475.29551.56","article-title":"Viability of porcine corneal epithelium ex vivo and effect of exposure to air: a pilot study for a dry eye model","volume":"23","author":"Choy","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2016.09.001_bb0940","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011119","article-title":"Lacrimal hypofunction as a new mechanism of dry eye in visual display terminal users","volume":"5","author":"Nakamura","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","article-title":"Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye","volume":"125","author":"Zheng","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009911","article-title":"Selenoprotein P controls oxidative stress in cornea","volume":"5","author":"Higuchi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb0955","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0008-8749(89)90166-4","article-title":"Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte cross-reaction","volume":"122","author":"Singh","year":"1989","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0960","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.142.5.1512","article-title":"Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis","volume":"142","author":"Singh","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0965","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/eji.200324058","article-title":"Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen","volume":"33","author":"Wildner","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0970","first-page":"677","article-title":"Multiple autoantigen mimotopes of infectious agents induce autoimmune arthritis and uveitis in lewis rats","volume":"12","author":"Wildner","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0975","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2004.01.002","article-title":"Autoimmune uveitis and antigenic mimicry of environmental antigens","volume":"3","author":"Wildner","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.001_bb0980","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.1830241103","article-title":"Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease","volume":"24","author":"Wildner","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0985","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/eji.1830260927","article-title":"Orally induced, peptide-specific gamma\/delta TCR+ cells suppress experimental autoimmune uveitis","volume":"26","author":"Wildner","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb0990","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-2478(97)00058-8","article-title":"Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC\u2013peptide crossreactive with autoantigen--first results","volume":"57","author":"Thurau","year":"1997","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2016.09.001_bb0995","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2478(99)00071-1","article-title":"Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis","volume":"68","author":"Thurau","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2016.09.001_bb1000","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1568-9972(03)00011-9","article-title":"An HLA-peptide mimics organ-specific antigen in autoimmune uveitis: its role in pathogenesis and therapeutic induction of oral tolerance","volume":"2","author":"Thurau","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"Suppl. A","key":"10.1016\/j.autrev.2016.09.001_bb1005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0896-8411(92)90040-W","article-title":"The expanding use of immunosuppression in the treatment of non-infectious ocular disease","volume":"5","author":"Nussenblatt","year":"1992","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb1010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000429649","article-title":"Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines","volume":"23","author":"Nussenblatt","year":"1992","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12886-016-0188-2","article-title":"Drug discovery in ophthalmology: past success, present challenges, and future opportunities","volume":"16","author":"Gower","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1025","first-page":"4886","article-title":"Anti-inflammatory effect of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on non-obese diabetic mice with Sjogren's syndrome","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S40798","article-title":"Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal","volume":"8","author":"Kashima","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/OPTH.S44688","article-title":"Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye","volume":"7","author":"Meerovitch","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1040","first-page":"491","article-title":"CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders","volume":"10","author":"West","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.autrev.2016.09.001_bb1045","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ICO.0b013e31823f789e","article-title":"Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye","volume":"31","author":"de Paiva","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2016.09.001_bb1050","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1167\/iovs.08-1880","article-title":"Neurologic evaluation of acute lacrimomimetic effect of cyclosporine in an experimental rabbit dry eye model","volume":"50","author":"Toshida","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb1055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4137\/OED.S7995","article-title":"Voclosporin as a treatment for noninfectious uveitis","volume":"5","author":"Schultz","year":"2013","journal-title":"Ophthalmol Eye Dis"},{"key":"10.1016\/j.autrev.2016.09.001_bb1060","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.intimp.2011.08.014","article-title":"Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjogren's syndrome mice","volume":"11","author":"Lin","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1167\/iovs.13-12925","article-title":"Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye","volume":"56","author":"Lin","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb1070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.exer.2015.06.032","article-title":"FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue","volume":"138","author":"Xiao","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb1075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-7843.2012.00896.x","article-title":"A highly soluble matrix metalloproteinase-9 inhibitor for potential treatment of dry eye syndrome","volume":"111","author":"Mori","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/08916930601167343","article-title":"Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity","volume":"40","author":"Hsu","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2016.09.001_bb1085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/ml2002482","article-title":"Discovery and Development of Potent LFA-1\/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye","volume":"3","author":"Zhong","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.autrev.2016.09.001_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045612","article-title":"Selenium compound protects corneal epithelium against oxidative stress","volume":"7","author":"Higuchi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb1095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02713680903453494","article-title":"The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model","volume":"35","author":"Seo","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb1100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/jop.1987.3.135","article-title":"The induction of tolerance by cyclosporine-G in experimental autoimmune uveitis in the Lewis rat","volume":"3","author":"Dinning","year":"1987","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0008-8749(88)90033-0","article-title":"Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis","volume":"113","author":"Caspi","year":"1988","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02713689308999487","article-title":"Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction","volume":"12","author":"Roberge","year":"1993","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb1115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-4835(05)80138-1","article-title":"Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism","volume":"61","author":"Chanaud","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2016.09.001_bb1120","first-page":"2211","article-title":"Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming","volume":"37","author":"Sartani","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb1125","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/eji.1830260510","article-title":"Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina","volume":"26","author":"Dick","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20050429","article-title":"Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity","volume":"203","author":"Grajewski","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb1135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0896-8411(91)90011-Z","article-title":"Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis","volume":"4","author":"Higuchi","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.001_bb1140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/08830180212067","article-title":"Bench to bedside: new approaches to the immunotherapy of uveitic disease","volume":"21","author":"Nussenblatt","year":"2002","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2016.09.001_bb1145","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1167\/iovs.10-6272","article-title":"Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis","volume":"52","author":"Haruta","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2016.09.001_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116518","article-title":"P2Y2R deficiency attenuates experimental autoimmune uveitis development","volume":"10","author":"Relvas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.001_bb1155","first-page":"727","article-title":"Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101","volume":"28","author":"Bar-Yehuda","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2016.09.001_bb1160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2353\/ajpath.2007.060236","article-title":"Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13","volume":"170","author":"de Kozak","year":"2007","journal-title":"Am J Pathol"}],"updated-by":[{"DOI":"10.1016\/j.autrev.2017.03.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000}}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:12:51Z","timestamp":1761599571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":232,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1568997216301938"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}